IRIS UniCatt

Salvatore, Lisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.579
AS - Asia 1.185
EU - Europa 752
SA - Sud America 287
AF - Africa 35
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.839
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.525
SG - Singapore 577
CN - Cina 249
BR - Brasile 234
IT - Italia 162
SE - Svezia 127
DE - Germania 109
VN - Vietnam 94
IN - India 77
FR - Francia 74
GB - Regno Unito 65
FI - Finlandia 52
IE - Irlanda 39
ID - Indonesia 34
HK - Hong Kong 30
AT - Austria 29
AR - Argentina 22
BD - Bangladesh 22
CA - Canada 22
KR - Corea 21
PL - Polonia 21
MX - Messico 20
RU - Federazione Russa 16
ZA - Sudafrica 14
TR - Turchia 13
JP - Giappone 12
EC - Ecuador 10
ES - Italia 9
IQ - Iraq 9
NL - Olanda 9
CZ - Repubblica Ceca 8
VE - Venezuela 8
IR - Iran 7
LT - Lituania 7
CI - Costa d'Avorio 6
RO - Romania 6
BE - Belgio 5
PK - Pakistan 5
SA - Arabia Saudita 5
UA - Ucraina 5
CO - Colombia 4
JM - Giamaica 4
KZ - Kazakistan 4
UZ - Uzbekistan 4
CH - Svizzera 3
DZ - Algeria 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
KE - Kenya 3
PY - Paraguay 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
MA - Marocco 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GR - Grecia 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.839
Salva come PNG Salva come JPEG
Città #
Ashburn 607
Singapore 308
Chandler 152
Los Angeles 79
Beijing 60
Rome 60
Hyderabad 57
New York 57
Hefei 54
Dublin 39
Munich 37
Ho Chi Minh City 34
Helsinki 33
Hong Kong 30
Jakarta 26
The Dalles 26
Chicago 25
São Paulo 25
Boston 23
Hanoi 23
Vienna 23
Seoul 21
Frankfurt am Main 17
Milan 17
Santa Clara 17
London 16
Marseille 16
Princeton 16
Dallas 15
Kent 14
Orem 13
Cattolica 12
Houston 12
Tokyo 12
Warsaw 12
Denver 11
Johannesburg 11
Lappeenranta 11
Nuremberg 11
Toronto 11
Mexico City 10
Bexley 9
Lauterbourg 9
Poplar 9
Wilmington 9
Buffalo 8
Columbus 8
Falkenstein 8
Moscow 8
Stockholm 8
Turku 8
Amsterdam 7
Atlanta 7
Bremen 7
Curitiba 7
Hamburg 7
Hải Dương 7
Montreal 7
Portsmouth 7
San Mateo 7
Abidjan 6
Manchester 6
Rio de Janeiro 6
Roubaix 6
Ankara 5
Bari 5
Brasília 5
Brooklyn 5
Buenos Aires 5
Düsseldorf 5
Kampong Loyang 5
Phoenix 5
Querétaro 5
Redmond 5
Salt Lake City 5
Seattle 5
Baghdad 4
Brdo 4
Brussels 4
Concord 4
Council Bluffs 4
Dhaka 4
Goiânia 4
Guayaquil 4
Haiphong 4
Kish 4
Secaucus 4
Tampa 4
Washington 4
Belo Horizonte 3
Bismarck 3
Blumenau 3
Boardman 3
Campinas 3
Hounslow 3
Istanbul 3
Kingston 3
Mumbai 3
Osasco 3
Palermo 3
Totale 2.369
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 591
The impact of the multidisciplinary tumor board (MDTB) on the management of pancreatic diseases in a tertiary referral center 157
THUNDER 2: THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI guided radiotherapy 147
Challenges in crohn’s disease management after gastrointestinal cancer diagnosis 135
Management of single pulmonary metastases from colorectal cancer: State of the art 132
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 128
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 115
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 115
Nutritional Interventions during Chemotherapy for Pancreatic Cancer: A Systematic Review of Prospective Studies 112
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis 107
The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience 104
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers 102
Bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: A meta-analysis of individual patients’ data from 3 phase III studies 100
Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine-DNA Methyltransferase-Silenced Metastatic Colorectal Cancer: The MAYA Trial 100
Role of chemoradiation (CRT) in the adjuvant treatment of radically resected pancreatic cancer (PC) patients (pts): a mono-institutional retrospective analysis 99
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer 97
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 95
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 93
Treatment of patients with BRAFV600E-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset 90
MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS 89
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 87
Role of Chemoradiation in the Adjuvant Treatment of Radically Resected Pancreatic Cancer Patients: A Mono-Institutional Retrospective Analysis 86
The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation 85
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab with or Without Atezolizumab for Patients with Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study 81
Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy 74
PTEN in colorectal cancer: Shedding light on its role as predictor and target 74
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 69
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C 67
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 60
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 60
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory KRAS G12C Colorectal Cancer 58
Challenges in Crohn's Disease Management after Gastrointestinal Cancer Diagnosis 56
Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience 55
Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial 55
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 53
Management of patients with early-stage colon cancer: Guidelines of the Italian Medical Oncology Association 53
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study 42
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: Lessons from the AtezoT RIBE study 41
Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistance 33
Totale 3.897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.146
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.146
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 5 5 0
2021/2022135 8 2 0 13 5 3 2 16 4 11 37 34
2022/2023435 42 46 35 68 36 53 26 27 42 14 16 30
2023/2024755 10 50 27 22 17 38 244 255 2 14 37 39
2024/2025921 12 11 57 32 53 40 73 31 102 120 235 155
2025/20261.621 291 117 207 459 455 92 0 0 0 0 0 0
Totale 3.897